• Profile
Close

Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group

International Journal of Gynecological Cancer Feb 02, 2018

Cioffi R, et al. - Researchers here analyzed menstrual and reproductive outcomes of women treated with single-agent vs multiagent chemotherapy for gestational trophoblastic neoplasia. Observations revealed a rare adverse effect of combined treatments ie the risk of premature ovarian failure. Except for this, both single-agent and multiagent chemotherapy could be safely administered to patients with a desire for childbearing. Compared to low-risk patients, high-risk patients have worse reproductive outcomes because they undergo hysterectomy more frequently.

Methods

  • Researchers identified 151 patients who were treated.
  • They excluded 76 patients older than 45 years, with a placental site or epithelioid trophoblastic tumor, undergoing hysterectomy for patient choice, or undergoing human chorionic gonadotropin follow-up at the time of the analysis.
  • According to International Federation of Gynecology and Obstetrics score, they divided 75 patients into subgroups: patients scoring less than 7, receiving single-agent chemotherapy (group A, n = 42); patients scoring 7 or greater, receiving combination treatment (group B, n = 33). Patients' outcomes were compared by univariate and multivariate analyses.

Results

  • In 33% of group A patients and 66.7% of group B (P=0.01), temporary amenorrhea occurred.
  • Three patients in group B showed premature menopause (0% vs 9%, P=0.02).
  • Salvage hysterectomy was performed on 10 patients in group B.
  • The 2 groups did not differ regarding pregnancy desire (P = 0.555).
  • Researchers observed that 57.1% in group A and 36.4% in group B became pregnant (P=0.060).
  • Instead, among high-risk patients not undergoing hysterectomy, pregnancy rate was 52.2% (57.1% vs 52.2%, P=0.449).
  • They noticed no difference in miscarriage (P = 0.479) and premature birth (P = 0.615) rates.
  • A multivariate analysis including age, International Federation of Gynecology and Obstetrics score, chemotherapy type, use of assisted reproductive technologies, previous pregnancies, and pregnancy desire revealed that only age (P=0.006) and pregnancy desire (P=0.002) had a significant impact on the probability to have subsequent pregnancies.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay